Clinical Trials Browser

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07000084 2026-04-07

GAIN-BCG

Phase 3 Recruiting

330 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07514897 2026-04-07

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Recruiting

250 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02845323 2026-04-06

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

Phase 2 Active not recruiting

15 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07510685 2026-04-03

IRIS

Phase NA Completed

240 enrolled

Genitourinary

Urinary Bladder Neoplasms, Prostatic Hyperplasia, Catheter-Related Infections

NCT05839119 2026-04-02

TASUC-Neo

Phase 1 Terminated

2 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07140315 2026-04-02

DK222 Study at Hopkins

Phase 1 Recruiting

6 enrolled

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07503795 2026-03-31

Outcomes of Definitive Radiotherapy for Bladder Cancer

Not yet recruiting

300 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05837767 2026-03-30

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Phase NA Recruiting

26 enrolled

BreastDermatologicGastrointestinalGenitourinarySarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase 1/2 Recruiting

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07420517 2026-03-30

DutaBCa-1

Phase 2 Recruiting

95 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT07463963 2026-03-30

RUPTURE

Phase NA Not yet recruiting

2,600 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07475403 2026-03-30

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Phase 2 Recruiting

53 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07495072 2026-03-27

PRO-GAG

Phase NA Recruiting

56 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis, Interstitial

NCT06447064 2026-03-25

(CLOCS-2)

Recruiting

2,900 enrolled

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Clinical Trials

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle

CISTO2

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

Measuring Surgical Recovery After Radical Cystectomy

ADAPT-BLADDER

ARID1A and/or KDM6A Mutation and CXCL13 Expression

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

LORUP

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

BladMetrix

VICKI

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

TOMBOLA

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

GAIN-BCG

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

IRIS

TASUC-Neo

DK222 Study at Hopkins

Outcomes of Definitive Radiotherapy for Bladder Cancer

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

DutaBCa-1

RUPTURE

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

PRO-GAG

(CLOCS-2)